April 18, 2011Date Released: 18 April 2011
CASE CCC IN THE NEWS
Leukemia Drug is Just One of Many Chemo Drugs in Short Supply
In the Works: Decoding Tumors in Search of More Effective Cancer Treatments
MARK YOUR CALENDARSCase CCC Scientific Series: Immunology
The next installment of the Case CCC Scientific Series is scheduled for Thursday, April 21 from 4-6:30 pm in Wolstein Auditorium (WRB 1-413). Drs. Anton Gorbachev, Neetu Gupta and Alex Huang will discuss the topic of Immunology:
Presentations will be followed by a short reception. All are encouraged to attend.Cancer Center Seminar Series: Development of a Prophylactic Breast Cancer Vaccine
Friday, April 22
Please join us Friday, April 22 at the next Cancer Center Seminar Series featuring Vincent K. Tuohy, PhD. Dr. Tuohy, Professor of Immunology, Molecular Medicine, and Pathology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Staff in the Department of Immunology at the Cleveland Clinic, will present Development of a Prophylactic Breast Cancer Vaccine.
Dr. Vincent K. Tuohy received his PhD in the Department of Pathology at the State University of New York, and completed his post-graduate training at Harvard Medical School. During his post-graduate training, Dr. Tuohy studied the immune response to the highly hydrophobic myelin proteolipid protein (PLP) and showed how an immune response to PLP was capable of inducing severe autoimmune demyelination of the central nervous system similar to what occurs in human multiple sclerosis. For his research efforts, Dr. Tuohy received the Harry Weaver Award from the National Multiple Sclerosis Society, the Peter W. Lampert Prize from the Society for Experimental Neuropathology, and the FIRST Award from the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Dr. Tuohy was recruited to the Cleveland Clinic in 1989 where he has extended his initial work on central nervous system autoimmunity by developing and characterizing autoimmune rodent models for deafness, heart failure, cystitis, prostatitis, ovarian failure, and breast failure. The ovarian and breast failure mouse models have been particularly useful in serving as novel cancer vaccination strategies for providing highly effective prevention and treatment of breast cancer and ovarian cancer. Dr. Tuohy serves as a consultant for the National Institutes of Health and the National Multiple Sclerosis Society, serves on the editorial board for several science journals, has trained over 20 postdoctoral fellows and graduate students, and has published over 85 manuscripts.Case CCC Annual Scientific Retreat
The Case CCC Annual Scientific Retreat will be July 8-9 at Corporate College East. Details will be posted soon.
FUNDING OPPORTUNITIESPilot Project Grants: American Cancer Society IRG Awards
The Case CCC is currently accepting applications for American Cancer Society Institutional Research Grant (IRG) awards. Pilot funding is available for projects in basic, clinical, prevention and control, behavioral, health services, and epidemiology cancer research with awards up to $30,000 for one-year cancer research projects that provide the basis for future independent grants.
IRG pilot project grants are intended to support independent, self-directed investigators early in their careers (assistant professor or equivalent). Applicants for the pilot project grants should be within 6 years of their first independent research or faculty appointment and eligible to apply for an independent national competitive research grant, but may not currently hold such a grant.
At the time of application, recipients of IRG pilot project grants must be citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application.
Instructions, frequently asked questions, and application forms are available at http://cancer.case.edu. Contact Terri Daso, Cancer Center Administration (844-7252,email@example.com) for more information.
LOI Deadline: June 13
The Robert Wood Johnson Foundation seeks to expand the evidence base for effective public health policy and practice through investment in Public Health Services and Systems Research (PHSSR). PHSSR examines the organization, financing and delivery of public health services within a community and determines the links between the quality and performance of the public health system and population health outcomes.
A web conference for interested applicants will be held April 27 at 3 pm. Registration is required.
Proposal Deadline: May 24
Message from Dr. David Wald, Scientific Director, Hematopoietic Stem Cell Core Facility
We appreciate your participation!
**All events are open to anyone interested in attending
Pathology Research Seminar
Physiology and Biophysics Seminar
Cancer Biology Fellow Seminar
Developmental Therapeutics Program (DTP) Meeting canceled
Hematology and Oncology Division Research Conference
Immunology Invited Speaker Seminar Series
NCRM Lunch and Learn
Pathology Graduate Student Seminar
Cancer Imaging Program (CIP) Drug Delivery Focus Group Meeting
Cancer Center Scientific Series: Immunology
Cancer Center Research in Progress Seminar canceled
Taussig Cancer Institute Grand Rounds canceled
Cancer Center Seminar Series
Case CCC Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Breast Cancer Detection and Management: Issues for 2011
Case CCC Annual Scientific Retreat
ADDITIONAL UPCOMING SEMINARS & EVENTS
Midwest Blood Club 9th Annual Symposium
2011 Clinical and Translational Research and Education Meeting: ACRT/SCTS Joint Annual Meeting
Cincinnati Cancer Symposium Series: 2011 Symposium on NF-κB, Cancer, Obesity, and Inflammation
4th International Symposium on Cancer Metastasis and the Lymphovascular System
2nd Annual Department of Medicine Research Day
Race for the Place
International Society for Stem Cell Research (ISSCR) Annual Meeting
Cancer Health Disparities Summit 2011
8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Avon Foundation Breast Cancer Research Program
Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC)
NIH BULLETIN – Notices and Funding Opportunities
Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research (Interagency U01)(PAR-11-203)
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.